Community post

Adaptive Phage Therapeutics (APT) is working toward a phage-based COVID vaccine — a phage engineered to express epitopes of SARS-CoV2 on the surface of the capsid. Phage-based vaccines are attractive because they are considered safe in the body and self-adjuvanted. APT is exploring the potential for an oral delivery system in the form of a lozenge.